Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...
Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine, a ...
Amid the measles outbreak, which is expected to “expand rapidly,” an expert explains how to stay protected from the virus ...
Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the ...
According to a study of the COVICAT cohort, almost one in four people infected with SARS-CoV-2 suffered from long-COVID. Long ...
Seismic Therapeutic, Inc., the machine learning immunology company, today announced the dosing of the first healthy subject ...
A team of scientists is investigating a new type of antibody, which stimulates the immune system to target cancer cells an ...
A new orally administered norovirus vaccine tablet has demonstrated promising safety and immunogenicity in older adults.
Patients with irritable bowel syndrome are more likely to benefit from a diet that eliminates any food triggering an IgG ...
Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, ...
“Because there was no commercial assay for detecting anti-measles virus IgG antibodies using a DBS sample, diagnostic laboratories have had to validate DBS on their own. Now we can fill this gap ...
2d
News Medical on MSNNew antibody reduces tumor growth in treatment-resistant breast and ovarian cancersA new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results